scholarly journals Endovascular management of a large aneurysm of the superior vena cava involving internal thoracic vein with remodeling technique

2016 ◽  
Vol 6 (3) ◽  
pp. 315-317 ◽  
Author(s):  
Loïc Griviau ◽  
Olivier Chevallier ◽  
Sylvain Favelier ◽  
Pierre Pottecher ◽  
Sophie Gehin ◽  
...  
2013 ◽  
Vol 37 (3) ◽  
pp. 825-828 ◽  
Author(s):  
Salah D. Qanadli ◽  
Tanina Rolf ◽  
Frederic Glauser ◽  
Dominique Delay ◽  
Catherine Beigelman-Aubry ◽  
...  

2019 ◽  
Vol 20 ◽  
pp. 713-718
Author(s):  
Mamoon H. Al-Omari ◽  
Qusai M. Aljarrah ◽  
Jehad Fataftah ◽  
Bashar Ghosheh ◽  
Zaid Manasara

2017 ◽  
Vol 34 (04) ◽  
pp. 398-408 ◽  
Author(s):  
Tamir Friedman ◽  
Keith Quencer ◽  
Sirish Kishore ◽  
Ronald Winokur ◽  
David Madoff

AbstractVenous obstruction in the cancer population can result in substantial morbidity and, in extreme cases, mortality. While venous obstruction can be caused by both benign and malignant etiologies in this population, the management of malignant venous obstruction as a palliative measure can be somewhat nuanced with respect to nonprocedural and procedural management, both with respect to treatment of the underlying malignancy as well as treatment of venous hypertension, which may be associated with venous thrombosis. Symptom severity, primary malignancy, functional status, and prognosis are all fundamental to the patient workup and dictate both the timing and extent of endovascular intervention. The morbidity and mortality associated with malignant obstructions of central venous structures, specifically the superior vena cava and inferior vena cava, can be significantly improved with endovascular management in appropriately selected patients. Thus, the pertinent literature regarding the clinical presentation, workup, and endovascular management of malignant central venous obstruction syndromes, with directed attention to superior vena cava syndrome and inferior vena cava syndrome, will be reviewed in this article.


2008 ◽  
Vol 7 (1) ◽  
pp. 80-83 ◽  
Author(s):  
Venkata Ramana Vollala ◽  
Narendra Pamidi ◽  
Bhagath Kumar Potu

The internal thoracic veins are venae comitantes of each internal thoracic artery draining the territory supplied by it and usually unite opposite the third costal cartilage. This single vein enters the corresponding brachiocephalic vein. We present a variation of right internal mammary vein draining into superior vena cava in a 45-year-old male cadaver. Likely development and clinical significance of the vein are discussed.


2018 ◽  
Vol 45 (4) ◽  
pp. 264-269 ◽  
Author(s):  
Jared B. Hooker ◽  
Beau M. Hawkins ◽  
Mazen S. Abu-Fadel

Superior vena cava syndrome has typically been associated with malignant conditions; however, the number of benign cases has started to grow as the use of upper-extremity venous lines and implantable cardiac devices increases. Whereas endovascular techniques are standardly used to treat patients with malignancies, the optimal care of patients with benign causes is less clear because they typically have longer life expectancies. We describe 2 cases of benign superior vena cava syndrome successfully managed with endovascular stenting, and we review the relevant literature. Of 145 cases in 10 series (average follow-up time, 24 mo), 96% of patients experienced symptomatic relief after endovascular management, with a primary patency rate of 66% and a secondary rate of 93%. Although few data exist to compare open surgical and endovascular techniques directly, both approaches appear to produce similar rates of patency. Both approaches frequently necessitate secondary intervention to maintain patency, but endovascular management is associated with fewer complications. We conclude that endovascular management of benign superior vena cava syndrome is a safe, effective, and reasonable initial management approach.


Sign in / Sign up

Export Citation Format

Share Document